폐기능 검사 시스템 시장 비즈니스 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Pulmonary Function Testing Systems Market was valued at USD 3.1 billion in 2025 and is estimated to grow at a CAGR of 6.9% to reach USD 5.9 billion by 2035.

The market is experiencing robust growth due to the rising prevalence of chronic respiratory conditions and supportive government initiatives that promote early diagnosis and management. Pulmonary function testing systems are critical tools for assessing lung performance, measuring airflow, lung volumes, and gas exchange efficiency. Increasing cases of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders, are driving adoption across hospitals, clinics, and home care settings. Innovations, including portable devices, advanced spirometers, and integrated analytical software, are enhancing diagnostic accuracy and patient comfort while promoting widespread acceptance. The industry is also witnessing growing use in occupational health monitoring, industrial applications, and home-based respiratory care. Digital health integration, remote monitoring capabilities, and the rising demand for compact, easy-to-use devices are accelerating the expansion of the pulmonary function testing systems market, particularly in regions emphasizing preventive healthcare and telemedicine solutions.

The handheld segment reached USD 1.8 billion in 2025. These portable devices are favored for their compact design, affordability, and ease of use, making them ideal for point-of-care and home-based monitoring. Handheld pulmonary function testing systems allow healthcare providers and patients to conduct assessments across diverse environments, promoting flexibility and convenience. The devices' cost-effectiveness enhances their adoption in small clinics, primary care centers, and resource-limited settings. The combination of accessibility, portability, and user-friendly features ensures that the handheld segment maintains its dominance, catering to both clinical and personal health monitoring needs.

The spirometry segment accounted for USD 1.4 billion in 2025 and is expected to grow at a CAGR of 7.2% through 2035. Spirometry remains a cornerstone diagnostic test for assessing lung function and detecting respiratory issues, such as airway obstruction and impaired airflow. Technological advancements, including digital interfaces, wireless connectivity, and integration with health data platforms, have made modern spirometers more precise, intuitive, and portable. These enhancements increase patient compliance and operational efficiency in clinical and home care environments, supporting wider adoption. As the demand for accurate, rapid, and user-friendly pulmonary assessments rises, spirometry systems are anticipated to remain a primary revenue contributor within the market.

U.S. Pulmonary Function Testing Systems Market captured USD 1.4 billion in 2025 and is projected to grow at a CAGR of 5.8% from 2026 to 2035. North America's leadership in medical technology innovation supports the rapid adoption of advanced pulmonary function testing systems, including digital and portable devices with wireless connectivity. Healthcare providers are increasingly investing in accurate, efficient, and patient-friendly diagnostic tools. Rising healthcare expenditure, coupled with regulatory frameworks emphasizing quality and early detection, further stimulates demand for pulmonary testing solutions. The U.S. market benefits from a combination of advanced infrastructure, high awareness of respiratory health, and increasing prevalence of chronic lung conditions, making it a key driver of global market growth.

Prominent players in the Global Pulmonary Function Testing Systems Market include Baxter, CHEST M.I, COSMED, ECO MEDICS, FUKUDA SANGYO, GANSHORN SCHILLER GROUP, Geratherm Respiratory, Medical Equipment Europe, MGC DIAGNOSTICS, MINATO MEDICAL SCIENCE, MORGAN, ndd Medical Technologies, PHILIPS, Vitalograph, and Vyaire MEDICAL. Key strategies adopted by companies in the Global Pulmonary Function Testing Systems Market focus on innovation, technological integration, and global expansion to strengthen market presence. Businesses are investing in R&D to develop portable, digital, and connected devices that enhance usability, accuracy, and patient engagement. Strategic partnerships, acquisitions, and collaborations are enabling access to new markets, advanced technologies, and manufacturing capabilities. Companies are also emphasizing customized solutions tailored for hospitals, clinics, and home-based monitoring to meet diverse consumer needs. Expanding distribution networks, enhancing customer support, and maintaining compliance with regulatory standards are critical tactics to improve brand trust and penetration. Additionally, firms are leveraging digital platforms to offer remote monitoring, data analytics, and telehealth solutions, ensuring a stronger foothold and competitive advantage in the market.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Test type trends
  • 2.2.4 Application trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in prevalence of chronic respiratory diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Favourable government initiatives
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory framework
    • 3.2.2.2 High cost associated with pulmonary function testing devices
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion of portable & wireless PFT devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape (Driven by Primary Research)
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Impact of AI and Generative AI on the Market (Driven by Primary Research)
• 3.8 Patent analysis
• 3.9 Pricing analysis, 2025 (Driven by Primary Research)
• 3.10 Customer insights
• 3.11 Porter's analysis
• 3.12 PESTEL analysis
• 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product type launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Handheld
• 5.3 Tabletop

Chapter 6 Market Estimates and Forecast, By Test Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Spirometry
• 6.3 Exercise stress test
• 6.4 Lung volume test
• 6.5 High altitude simulation testing
• 6.6 Gas diffusion test
• 6.7 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Chronic obstructive pulmonary disease
• 7.3 Asthma
• 7.4 Chronic shortness of breath
• 7.5 Pulmonary fibrosis
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals & clinics
• 8.3 Diagnostic centers
• 8.4 Homecare settings
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Baxter
• 10.2 CHEST M.I
• 10.3 COSMED
• 10.4 ECO MEDICS
• 10.5 FUKUDA SANGYO
• 10.6 GANSHORN SCHILLER GROUP
• 10.7 Geratherm Respiratory
• 10.8 medical equipment Europe
• 10.9 MGC DIAGNOSTICS
• 10.10 MINATO MEDICAL SCIENCE
• 10.11 MORGAN
• 10.12 ndd Medical Technologies
• 10.13 PHILIPS
• 10.14 Vitalograph
• 10.15 Vyaire MEDICAL